Thyroiditis After IL-2 and Interferon Treatment
Author Information
Author(s): G. Pichert, L.M. Jost, L. Z6beli, B. Odermatt, G. Pedio, R.A. Stahel
Primary Institution: University Hospital, Zurich, Switzerland
Hypothesis
Does treatment with interleukin-2 and interferon alpha-2a lead to thyroid dysfunction in patients with melanoma and renal cell carcinoma?
Conclusion
Half of the patients treated with interleukin-2 and interferon alpha-2a experienced transient thyroid dysfunction due to autoimmune thyroiditis.
Supporting Evidence
- Four out of eight patients developed thyroid dysfunction after treatment.
- Thyroid dysfunction included a hyperthyroid phase followed by a hypothyroid phase.
- Fine-needle aspirates showed evidence of autoimmune thyroiditis in three patients.
Takeaway
Some patients who received a specific cancer treatment had problems with their thyroid, which means their thyroid didn't work right for a while.
Methodology
Eight patients with melanoma or renal cell carcinoma were treated with interleukin-2 and interferon alpha-2a, and their thyroid functions were monitored.
Limitations
The study had a small sample size and focused only on patients who completed at least three cycles of treatment.
Participant Demographics
Patients included both males and females with metastatic melanoma or renal cell carcinoma.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website